Role of TGF-β1 on the IgE-dependent anaphylaxis reaction

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4960-4965

  Kim, Hyung Min ^a   Lee, Young Mi ^a  

^a Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLYASE; CYCLIC AMP; HISTIDINE; IMMUNOGLOBULIN E; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; HISTAMINE RELEASE; IMMUNOPATHOGENESIS; IN SITU HYBRIDIZATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033561765     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Galli, S. J. 1993. New concepts about the mast cell. N. Engl. J. Med. 328:257.
2. Metcalf, D. D., J. J. Costa, and P. R. Burd. 1992. Mast cells and basophils. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, R. Wnyderman, eds. Raven Press, New York, p 709.
3. Tsai, M., J. R. Gordon, and S. J. Galli. 1990. Mast cells constitutively express transforming growth factor β mRNA. FASEB J. 4:AI944.
4. Pennington, D. W., A. R. Lopez, P. S. Thomas, C. Peck, and W. M. Gold. 1992. Dog mastocytoma cells produce transforming growth factor β. J. Clin. Invest. 90:35.
5. Kovacs, E. J. 1991. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol. Today 12:17.
6. Choi, K. L., and H. N. Claman. 1987. Mast cell, fibroblasts, and nbrosis: new clues to the riddle of mast cells. Immunol. Res. 6:145.
7. Leiferman, K. M., S. J. Ackerman, H. A. Sampson, H. S. Haugen, P. Y. Venencie, and G. J. Gleich. 1985. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis: comparison with onchocerciasis. N. Engl. J. Med. 313:282.
8. Claman, H. N. 1993. Mast cells and fibrosis: hints from graft-versus-host disease and scleroderma. In The Mast Cell in Health and Disease. M. A. Kaliner, and D. D. Metcalfe, eds. Marcel Dekker, New York, p 653.
9. Gordon, J. R., and S. J. Galli. 1994. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the FcεRI: role for mast cell-derived transforming growth factor β and tumor necrosis factor α. J. Exp. Med. 180:2027.
10. Petersen, L. J., H. Mosbech, and P. Skov. 1996. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J. Allergy Clin. Immunol. 97:672.
11. Gordon, J. R, and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346:274.
12. Segal, D. M., J. Taurog, and H. Metzger. 1977. Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. Proc. Natl. Acad. Sci. USA 74:2993.
13. Metzger, H., G. Alcaraz, R. Hohman, J. P. Kinet, V. Pribluda, and R. Quarto. 1986. The receptor with high affinity for immunoglobulin E. Annu. Rev. Immunol. 4:419.
14. Alber, G., L. Miller, C. Jelsema, N. Varin-Blank, and H. Metzger. 1991. Structure/function relationships in the mast cell high-affinity receptor for IgE (FcεRI): role of cytoplasmic domains. J. Biol. Chem. 266:22613.
15. Saito, H., and Y. Nomura. 1989. Screening methods for durg evaluation 3. In Pharmaceutical Research and Development L. Suzuki, H. Tanaka, H. Yajima, H. Fukuda, H. Sezaki, K. Koga, M. Hirobe, and T. Nakajime, eds. Hirokawa, Tokyo, p 22.
16. Stricter, R. M., S. L. Kunkel, and R. C. Bone. 1993. Role of tumor necrosis factor-α in disease states and inflammation. Crit. Care Med. 21:S447.
17. Larrick, J. W., and S. C. Wright. 1990. Cytotoxic mechanism of tumor necrosis factor-α. FASEB J. 4:3215.
18. Rosenblum, M. G., and N. J. Donate. 1989. Tumor necrosis factor-α: a multi-faceted peptide hormone. Crit. Rev. Immunol. 9:21.
19. Derynck, R., J. A. Jarrett, E. Y. Chen, and D. V. Goeddel. 1986. The murine transforming growth factor-β precursor. J. Biol. Chem. 262:4377.
20. Kalayama, S., H. Shionoya, and S. Ohteke. 1978. A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol. Immunol. 22:89.
21. Shin, B. K., E. H. Lee, and H. M. Kim. 1997. Suppression ofL-histidine decarboxylase mRNA expression by methyleugenol. Biochem. Biophys. Res. Commun. 232:188.
22. Yurt, R. W., R. W. Leid, and K. F. Austen. 1977. Native heparin from rat peritoneal mast cells. J. Biol. Chem. 252:518.
23. Shore, P. A., A. Burkhalter, and V. H. Cohn. 1959. A method for fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 127:182.
24. Peachell, P. T., D. W. Macglashan, L. M. Lichtenstein, and R. P. Schleimer. 1988. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J. Immunol. 140:571.
25. Scuderi, P., R. E. Sterling, K. S. Lam, P. R. Finley, K. J. Ryan, C. G. Ray, E. Petersen, D. J. Slymen, and S. E. Salmon. 1986. Raised serum levels of tumor necrosis factor in parasitic infections. Lancet 2:1364.
26. Auffray, C., and F. Rougenon. 1980. Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biol. 107:303.
27. Yamamoto, J., K. Yatsunami, E. Ohmori, Y. Sugimoto, T. Fukui, T. Katayama, and A. Ichikawa. 1990. cDNA-derived amino acid sequence of L-histidine decarboxylase from mouse mastocytoma P-815 cells. FEBS Lett. 276:214.
28. Kim, H. M., S. Hirota, H. T. Chung, S. Ohno, S. I. Osada, T. K. Shin, K. I. Ko, J. B. Kim, Y. Kitamura, and S. Nomura. 1992. Localization and developmental expression of a novel protein kinase C δ gene. Dev. Brain Res. 70:239.
29. Sellheyer, K., J. R. Bickenbach, J. A. Rothnagel, D. Bundman, M. A. Longley, T. Krieg, N. S. Roche, A. B. Roberts, and D. R. Roop. 1993. Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice. Proc. Natl. Acad. Sci. USA 90:5237.
30. Makino, H., T. Saijo, Y. Ashida, H. H. Kuriki, and Y. Maki. 1987. Mechanism of action of an antiallergic agent, Amlexanox (AA-673), in inhibiting histamine release from mast cells. Int. Arch. Allergy Immunol. 82:66.
31. Bissonnette, E. Y., J. A. Enciso, and A. D. Befus. 1997. TGF-β1 inhibits the release of histamine and tumor necrosis factor-α from mast cells through an autocrine pathway. Am. J. Respir. Cell Mol. Biol. 16:275.